financetom
Market
financetom
/
Market
/
Sebi fines brokerage firm, Anand Rathi for violating stock broker norms
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sebi fines brokerage firm, Anand Rathi for violating stock broker norms
Nov 27, 2018 8:31 PM

Markets regulator Sebi on Tuesday fined brokerage house Anand Rathi Rs 1 lakh for violating stock broker norms by transferring funds from the client's account to own account and vice versa on several occasions.

Share Market Live

NSE

In an order, the regulator said that Anand Rathi Shares and Stock Brokers has mixed-up client's funds with its own funds and vice versa and thereby acted in contravention of Sebi (Stock Brokers and Sub-Brokers) Regulations.

The regulator had outlined strict segregation of client's funds, member account's funds and transfer of funds is permitted as an exception under specific instances.

However, the scheme of arrangement regarding transfer of money made by the Anand Rathi is not in accordance with the permissible conditions under the stock brokers norms which makes it liable for monetary penalty, Sebi noted.

Accordingly, the Securities and Exchange Board of India (Sebi) imposed a fine on the firm.

In a separate order, Sebi has levied a total penalty of Rs 5 lakh on four persons for failing to make disclosure about change in their shareholding in SMS Techsoft Ltd within the required timeline.

The persons facing penalties are Kirtikumar Rasiklal Shah, Alkaben Kirtibhai Shah, Karan Kirtibhai Shah and Kewal Kirtikumar Shah.

According to Sebi, these four persons, who were acting in concert, collectively acquired over 39 lakh shares of the company, which resulted in cumulative change in their shareholding.

However, they failed to mandatory disclosure about this as required under SAST (Substantial Acquisition of Shares & Takeovers) Regulations to the company and BSE.

First Published:Nov 28, 2018 5:31 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-Wall St set for muted open in countdown to Nvidia earnings
US STOCKS-Wall St set for muted open in countdown to Nvidia earnings
Aug 27, 2025
* Futures: Dow flat, S&P 500 off 0.03%, Nasdaq slips 0.06% * MongoDB ( MDB ) soars after raising annual profit forecast * Cracker Barrel retains logo after social media backlash * Kohl's gains after raising annual profit forecast (Updates before market opens) By Johann M Cherian and Sanchayaita Roy Aug 27 (Reuters) - Wall Street's main indexes were set...
Sector Update: Tech Stocks Advance Premarket Wednesday
Sector Update: Tech Stocks Advance Premarket Wednesday
Aug 27, 2025
09:08 AM EDT, 08/27/2025 (MT Newswires) -- Technology stocks were advancing premarket Wednesday, as the Technology Select Sector SPDR Fund (XLK) was up 0.1% and the SPDR S&P Semiconductor ETF ( XSD ) was 1.5% higher recently. MongoDB's ( MDB ) shares were up more than 30% in premarket activity Wednesday after the company reported overnight quarterly earnings and sales...
COLUMN-Danger ahead! Five examples of risky central bank politicization: McGeever
COLUMN-Danger ahead! Five examples of risky central bank politicization: McGeever
Aug 27, 2025
(The opinions expressed here are those of the author, a columnist for Reuters.) By Jamie McGeever ORLANDO, Florida, Aug 27 (Reuters) - There is legitimate debate about the actual independence of modern-day central banks, but almost everyone agrees that overt politicization of monetary policy - as we appear to be seeing in the United States - is dangerous. Why is...
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday
Aug 27, 2025
09:10 AM EDT, 08/27/2025 (MT Newswires) -- Health care stocks were mixed premarket Wednesday, as the Health Care Select Sector SPDR Fund ( XLV ) was up 0.1% and the iShares Biotechnology ETF (IBB) was down 0.4%. Eli Lilly ( LLY ) said that its experimental drug Verzenio, combined with endocrine therapy, showed a statistically significant improvement in overall survival...
Copyright 2023-2026 - www.financetom.com All Rights Reserved